Similar to previous seasons, the Centers for Disease Control and Prevention is recommending that all Americans ages 6 months and older get a shot of the "updated 2024-2025 COVID-19 vaccine" to protect against another expected surge of the virus this fall and winter. In a presentation to th...
Moderna's new version of its COVID-19 vaccine, which targets two virus variants including Omicron, has outperformed the company's original Spikevax shot in a head-to-head clinical trial. mRNA-1273.214 stimulated almost twice the neutralising antibody lev
A new report accuses American drugmaker Moderna of prioritizing profits from COVID-19 vaccines by keeping poor countries waiting. The New York Times says the vaccine maker has sold most of its doses to wealthier nations. Only one million doses have gone to low-income countries...
The art of COVID-19 communication Call for global biodiversity agreementModerna said it is looking at whether a booster shot – either of its existing vaccine or of a new shot designed to protect against the South Africa variant – could be made available in future if evidence...
article FILE - Vials containing Moderna COVID-19 vaccine.WASHINGTON - Drugmaker Moderna asked the Food and Drug Administration on Thursday to authorize a fourth shot of its COVID-19 vaccine as a booster dose for all adults.The request is broader than rival pharmaceutical company Pfizer's ...
Public health officials in both Denmark and Sweden, countries which are routinely praised by the far left in America, have paused the use of Moderna’s vaccine for people under 30 years of age, citing an increased risk of heart problems associated with the COVID shot. ...
Moderna: good news on skin cancer vaccine is welcome distraction from Covid-19 shot sales woes Premium content US biotech company’s stock worth nearly $500 at its peak in August 2021, currently trades at less than $87 Save December 5 2023 Legal services Standout examples of in-house la...
Canada on Thursday authorized an updated Moderna COVID-19 booster shot that specifically targets the Omicron variant and is said to provide significantly better protection against it. In a summary of the decision, Health Canada said clinical trials of the new bivalent vaccine induced significantly hig...
Moderna says its COVID-19 vaccine strongly protects kids as young as 12. The company released the preliminary findings Tuesday based on testing on more than 3,700 12- to 17-year-olds in the United States.
Shares of Moderna (MRNA) lost 6.5%, marking Thursday's weakest performance in the S&P 500. The share price drop coincided with the approval of Moderna's vaccine to protect against new strains of COVID-19. The Centers for Disease Control (CDC) recommends an updated shot for al...